Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Clinical/Lab Features
fibrous crescents typically present on renal histopathology
RBC casts and/or dysmorphic RBCs in urine
classified by immunofluorescence staining
Type I: Anti-GBM mediated (15% of cases)
Type II: Immune Complex Mediated (24% of cases)
Type III: Non-Immune Mediated (60% of cases)
Type IV: Double Antibody Positive
treatment: underlying cause for postinfectious; corticosteroids + cyclophosphamide or other
cytotoxic agent + plasmaphoresis in select cases
prognosis: 50% recovery with early treatment, depends on underlying cause
3. NEPHROTIC SYNDROME
Clinical/Lab Features
heavy proteinuria (>3.5 g/1.73m2/d)
hypoalbuminemia
edema
hyperlipidemia (elevated LDL cholesterol), lipiduria (fatty casts and oval fat bodies on
microscopy)
hypercoagulable state (due to antithrombin III, Protein C, and Protein S urinary losses)
patient may report frothy urine
glomerular pathology on renal biopsy
minimal change disease (or minimal lesion disease or nil disease) e.g. glomeruli appear
normal on light microscopy
membranous glomerulopathy
focal segmental glomerulosclerosis (FSGS)
membranoproliferative GN
nodular glomerulosclerosis
each can be idiopathic or secondary to a systemic disease or drug (sirolimus can cause
proteinuria without obvious glomerular pathology)
Table 10. Nephrotic Syndrome
Minimal
Change
Membranous
Glomerulopathy
Focal Segmental
Membranoproliferative
Glomerulosclerosis Glomerulonephritis
Nodular
Glomerulosclerosis
Secondary
Causes
Hodgkins
lymphoma
Reflux nephropathy,
HIV, HBV, obesity
DM, amyloidosis
Drug Causes
NSAIDs
Therapy
Steroids
Treat underlying
cause
Steroids, ACEI/ARB
for proteinuria